The EBF1/RBP7 regulatory axis was suggested to influence downstream pathways, including the Th2 immune response and oocyte meiosis-related signaling, thereby enhancing the malignant potential of BLCA cells and promoting bone metastasis. The gene discussed is RBP7; the disease is bladder transitional cell carcinoma.